Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2023
ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancerGráinne Sheill, Lauren Brady, Brian Hayes, et al.Cancers|September 28, 2021
Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)Brian Hayes, Lauren Brady, Gráinne Sheill, et al.Scientific Reports|June 20, 2020
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancerAna Barat, Dominiek Smeets, Bruce Moran, et al.Therapeutic Advances in Medical Oncology|August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trialGiuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.Journal of Cancer Policy|February 25, 2023
Impact of the COVID-19 pandemic on cancer care in Ireland - Perspectives from a COVID-19 and Cancer Working GroupSeamus O'Reilly, Hailey Kathryn Carroll, Deirdre Murray, et al.Nature Communications|October 7, 2018
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapyDominiek Smeets, Ian S Miller, Darran P O'Connor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2018
Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With BevacizumabErik van Dijk, Hedde D Biesma, Martijn Cordes, et al.Molecular Oncology|February 24, 2026
Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancerRodrigo Dienstmann, Eduardo García-Galea, Alice O'Farrell, et al.Pageof 2